Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED): A Randomized, Double-blind, Placebo-controlled Trial

NCT04225819 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04225819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04225819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED): A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Suspended
Start date
October 1, 2020
Completion date
April 1, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ibd, inflammatory bowel diseases, ulcerative colitis, vitamin d3 deficiency